prednisolone has been researched along with Malignant Mesothelioma in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Okamoto, S | 1 |
Tsuboi, H | 1 |
Sato, R | 1 |
Terasaki, M | 1 |
Terasaki, T | 1 |
Toko, H | 1 |
Shimizu, M | 1 |
Honda, F | 1 |
Yagishita, M | 1 |
Ohyama, A | 1 |
Kurata, I | 1 |
Abe, S | 1 |
Takahashi, H | 1 |
Osada, A | 1 |
Hagiwara, S | 1 |
Kondo, Y | 1 |
Matsumoto, I | 1 |
Sumida, T | 1 |
1 review available for prednisolone and Malignant Mesothelioma
Article | Year |
---|---|
IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review.
Topics: Adult; Aged; Aortitis; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunoglobulin G4-R | 2020 |